Infertility is the symptom of an underlying cause. It can be caused by one or various pathologies.  In order to treat infertility one has to get to the root of the cause.

  This is what NaProTechnology® offers and the results are exciting and promising.


Thomas W. Hilgers, M.D., director of the Pope Paul VI Institute for the Study of Human Reproduction in Omaha, Nebraska, developed NaPro Technology® and has dedicated his medical career to this research.  “Natural Procreative Technology”, is a holistic medical evaluation and treatment for gynaecologic and reproductive health abnormalities.

 This video in two parts explains a couples experience with NaProTechnology® to treat their infertility.

Couples are first taught how to chart the womans fertility signs (The Creighton Model FertilityCare System or CrMS). The information charted by the couple, allows the Doctor who is trained in CrMS and NaProTechnology®,  to conduct a more thorough evaluation of the fertility cycle to identify abnormal menstrual bleeding patterns, poor cervical mucus flow and subtle hormonal deficiencies that are often not detected by routine gynaecologic assessment.


The goal is to return the woman’s biological markers on the fertility chart to normal and  an optimum fertility potential for the couple. NaProTechnology® uses many medications that are widely used in other fertility programmes, but the precise timing and monitoring of treatment using the CrMS charting system is unique to NaProTechnology®

When fertility is restored to its optimum function, conception can occur anywhere from the first to the twelfth effective cycle of treatment. On average couples complete fertility evaluation and treatment between 18 to 24 months after the initial medical consultation, or sooner if conception occurs.  Furthermore, couples that are at increased risk of miscarriage can usually be identified and treated even before they have their first pregnancy loss.


    This next diagram shows a comparison made of the per woman pregnancy rates between the NaProTechnology® approach and In Vitro Fertilization (IVF). This study shows that  women treated with NaPro Technology® have statistically significantly higher pregnancy rates than patients with similar conditions treated with IVF. In this study 12 effective cycles of treatment with NaProTechnology® were compared with one attempt of IVF.  Repeated attempts at IVF will have higher live birth rates.

       By knowing their fertile days, married 

couples can use Fertility Focused 

Intercourse to achieve pregnancy.

      20-40% of couples with infertility have

 achieved pregnancy by just using the CrMS.  

    The earlier problems are identified and 

treated, the greater the likelihood of a

 successful outcome.                            

 NaPro Technology® vs. Other

Infertility Treatment

NaPro Technology® unlike the other infertility treatments gets to the root of the underlying medical condition causing the infertility rather than overriding the cause to enable pregnancy. It assists the couple in achieving pregnancy whilst maintaining the natural acts of procreation. If the treatment programme is unsuccessful, research into the unknown cause is undertaken. If medically unsuccessful, the programme will assist family building by being supportive of adoption.

 The Goals of NaProTECHNOLOGY®in Infertility

The NaProTECHNOLOGY® approach to the infertile couple has the following goals:

  • It works towards assessing the underlying causes of the reproductive abnormality.
  • It allows for the treatment of these underlying causes.
  • It assists the couple in achieving pregnancy while maintaining the natural acts of procreation.
  • If the treatment program is unsuccessful, research into the unknown causes is undertaken.
  • If medically unsuccessful, the program will assist with successful family building by being supportive of adoption.

Infertility Options 
is a very informative blog about NaPro Technology.  
Click here to find their top reasons for choosing NaPro Technology:

 What About IVF? 

Please click on this link for further information: